Adverse Effects of Statins - Myths and Reality
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
1220-1226
Author(s):
Iveta Simic and Zeljko Reiner
Tea (Camellia sinensis (L.)): A Putative Anticancer Agent in Bladder Carcinoma?
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
15
Page:
26-36
Author(s):
Vanessa R. Conde, Marco G. Alves, Pedro F. Oliveira and Branca M. Silva
Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists
Journal:
Current Topics in Medicinal Chemistry
Volume:
14
Page:
2188-2205
Author(s):
Christina Lamers, Manfred Schubert-Zsilavecz and Daniel Merk
The Interactions of Anticancer Agents with Tea Catechins: Current Evidence from Preclinical Studies
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
1343-1350
Author(s):
Weihu Shang, Weidong Lu, Mei Han and Jinping Qiao
Genistein: A Phytoestrogen with Multifaceted Therapeutic Properties
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
14
Page:
920-940
Author(s):
Sukanya Saha, Pritam Sadhukhan and Parames C. Sil
Curcumin in Combined Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6682-6696
Author(s):
Koraljka Gall Troselj and Renata Novak Kujundzic
The Exploitation of Toll-like Receptor 3 Signaling in Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6555-6564
Author(s):
Tanja Matijevic Glavan and Jasminka Pavelic
Hepatic MicroRNA Orchestra: A New Diagnostic, Prognostic and Theranostic Tool for Hepatocarcinogenesis
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
14
Page:
837-852
Author(s):
Alex Boye and Yan Yang
Conventional Anticancer Therapeutics and Telomere Maintenance Mechanisms
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6452-6465
Author(s):
Orit Uziel and Meir Lahav
Editorial (Thematic Issue: New Advances of Drug Design in Cancer Disease Part II)
Journal:
Current Bioactive Compounds
Volume:
10
Page:
139-139
Author(s):
Carlton A. Taft